跳至主要内容
临床试验/NCT07732582
NCT07732582尚未招募不适用

Exploratory Study on Characterizing Region-Specific Gastrointestinal and Oral Microbiomes in Sjögren's Disease Using Novel Ingestible Mini-Pill Sampling Technology

Tufts University1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2026年8月31日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
90
试验地点
1
主要终点
Microbial

研究概览

简要总结

The goal of this observational study is to characterize and compare region-specific gastrointestinal, stool, oral, and periodontal microbiomes in adults with Sjögren's disease and healthy controls using ingestible mini-pill sampling technology. The study will include adults with Sjögren's disease and healthy control participants enrolled in a parent gastrointestinal microbiome study

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Group 1: Control
  • Currently enrolled in and willing to share data from the parent study of "Evaluation of Ingestible Mini-pill for Gastrointestinal Regional Luminal Content Sampling" at Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University.
  • Willing to provide saliva and periodontal plaque from the deepest periodontal pocket.
  • Able to understand study requirements and procedures, and willing to sign informed consent prior to participation.
  • Group 2: Sjogren's Cohort
  • Adult Sjogren's Disease participants diagnosed according to the 2016 American European criteria
  • Willing to donate saliva and periodontal plaque from the deepest periodontal pocket.
  • Able and willing to perform home stool collection and recovery of GI sampling capsules.

排除标准

  • Control Group:
  • Those not participating in parent study, "Evaluation of Ingestible Mini-pill for Gastrointestinal Regional Luminal Content Sampling" at HNRCA.
  • Unable to understand or unwilling to sign the informed consent form.
  • Any medical conditions requiring antibiotic prophylaxis prior to dental procedures (e.g., certain cardiac conditions, prosthetic joints). Upon interviewing the potential subject, no periodontal sample will be taken. Only saliva samples will be taken in these cases.
  • Presence of active disease of the hard or soft oral tissues.
  • History of salivary gland disorders, such as Sjögren's syndrome, sarcoidosis, or prior head and neck radiation therapy.
  • If a subject needs to undergo new dental or periodontal treatment (including scaling, root planing, or antibiotic irrigation) while enrolled in our study
  • Sjogren's Cohort:
  • Pregnant or breast feeding
  • Requiring antibiotic prophylaxis before dental procedures
  • HIV/AIDS, sarcoidosis, or prior head and neck radiation therapy.

结局指标

主要结局

Microbial

时间窗: 3-8 weeks

The primary outcome will be overall microbial community composition

Sjogren's Microbiome Relationship

时间窗: 3 weeks

To evaluate the relationship of salivary and periodontal plaque microbiomes in the Sjogren's group to their gut and stool microbiome.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验